Cargando…
Spleen tyrosine kinase mediates innate and adaptive immune crosstalk in SARS‐CoV‐2 mRNA vaccination
Durable cell‐mediated immune responses require efficient innate immune signaling and the release of pro‐inflammatory cytokines. How precisely mRNA vaccines trigger innate immune cells for shaping antigen specific adaptive immunity remains unknown. Here, we show that SARS‐CoV‐2 mRNA vaccination prime...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9349614/ https://www.ncbi.nlm.nih.gov/pubmed/35785445 http://dx.doi.org/10.15252/emmm.202215888 |
_version_ | 1784762137562841088 |
---|---|
author | Theobald, Sebastian J Simonis, Alexander Mudler, Julie M Göbel, Ulrike Acton, Richard Kohlhas, Viktoria Albert, Marie‐Christine Hellmann, Anna‐Maria Malin, Jakob J Winter, Sandra Hallek, Michael Walczak, Henning Nguyen, Phuong‐Hien Koch, Manuel Rybniker, Jan |
author_facet | Theobald, Sebastian J Simonis, Alexander Mudler, Julie M Göbel, Ulrike Acton, Richard Kohlhas, Viktoria Albert, Marie‐Christine Hellmann, Anna‐Maria Malin, Jakob J Winter, Sandra Hallek, Michael Walczak, Henning Nguyen, Phuong‐Hien Koch, Manuel Rybniker, Jan |
author_sort | Theobald, Sebastian J |
collection | PubMed |
description | Durable cell‐mediated immune responses require efficient innate immune signaling and the release of pro‐inflammatory cytokines. How precisely mRNA vaccines trigger innate immune cells for shaping antigen specific adaptive immunity remains unknown. Here, we show that SARS‐CoV‐2 mRNA vaccination primes human monocyte‐derived macrophages for activation of the NLRP3 inflammasome. Spike protein exposed macrophages undergo NLRP3‐driven pyroptotic cell death and subsequently secrete mature interleukin‐1β. These effects depend on activation of spleen tyrosine kinase (SYK) coupled to C‐type lectin receptors. Using autologous cocultures, we show that SYK and NLRP3 orchestrate macrophage‐driven activation of effector memory T cells. Furthermore, vaccination‐induced macrophage priming can be enhanced with repetitive antigen exposure providing a rationale for prime‐boost concepts to augment innate immune signaling in SARS‐CoV‐2 vaccination. Collectively, these findings identify SYK as a regulatory node capable of differentiating between primed and unprimed macrophages, which modulate spike protein‐specific T cell responses. |
format | Online Article Text |
id | pubmed-9349614 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-93496142022-08-04 Spleen tyrosine kinase mediates innate and adaptive immune crosstalk in SARS‐CoV‐2 mRNA vaccination Theobald, Sebastian J Simonis, Alexander Mudler, Julie M Göbel, Ulrike Acton, Richard Kohlhas, Viktoria Albert, Marie‐Christine Hellmann, Anna‐Maria Malin, Jakob J Winter, Sandra Hallek, Michael Walczak, Henning Nguyen, Phuong‐Hien Koch, Manuel Rybniker, Jan EMBO Mol Med Articles Durable cell‐mediated immune responses require efficient innate immune signaling and the release of pro‐inflammatory cytokines. How precisely mRNA vaccines trigger innate immune cells for shaping antigen specific adaptive immunity remains unknown. Here, we show that SARS‐CoV‐2 mRNA vaccination primes human monocyte‐derived macrophages for activation of the NLRP3 inflammasome. Spike protein exposed macrophages undergo NLRP3‐driven pyroptotic cell death and subsequently secrete mature interleukin‐1β. These effects depend on activation of spleen tyrosine kinase (SYK) coupled to C‐type lectin receptors. Using autologous cocultures, we show that SYK and NLRP3 orchestrate macrophage‐driven activation of effector memory T cells. Furthermore, vaccination‐induced macrophage priming can be enhanced with repetitive antigen exposure providing a rationale for prime‐boost concepts to augment innate immune signaling in SARS‐CoV‐2 vaccination. Collectively, these findings identify SYK as a regulatory node capable of differentiating between primed and unprimed macrophages, which modulate spike protein‐specific T cell responses. John Wiley and Sons Inc. 2022-07-04 /pmc/articles/PMC9349614/ /pubmed/35785445 http://dx.doi.org/10.15252/emmm.202215888 Text en © 2022 The Authors. Published under the terms of the CC BY 4.0 license. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Articles Theobald, Sebastian J Simonis, Alexander Mudler, Julie M Göbel, Ulrike Acton, Richard Kohlhas, Viktoria Albert, Marie‐Christine Hellmann, Anna‐Maria Malin, Jakob J Winter, Sandra Hallek, Michael Walczak, Henning Nguyen, Phuong‐Hien Koch, Manuel Rybniker, Jan Spleen tyrosine kinase mediates innate and adaptive immune crosstalk in SARS‐CoV‐2 mRNA vaccination |
title | Spleen tyrosine kinase mediates innate and adaptive immune crosstalk in SARS‐CoV‐2 mRNA vaccination |
title_full | Spleen tyrosine kinase mediates innate and adaptive immune crosstalk in SARS‐CoV‐2 mRNA vaccination |
title_fullStr | Spleen tyrosine kinase mediates innate and adaptive immune crosstalk in SARS‐CoV‐2 mRNA vaccination |
title_full_unstemmed | Spleen tyrosine kinase mediates innate and adaptive immune crosstalk in SARS‐CoV‐2 mRNA vaccination |
title_short | Spleen tyrosine kinase mediates innate and adaptive immune crosstalk in SARS‐CoV‐2 mRNA vaccination |
title_sort | spleen tyrosine kinase mediates innate and adaptive immune crosstalk in sars‐cov‐2 mrna vaccination |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9349614/ https://www.ncbi.nlm.nih.gov/pubmed/35785445 http://dx.doi.org/10.15252/emmm.202215888 |
work_keys_str_mv | AT theobaldsebastianj spleentyrosinekinasemediatesinnateandadaptiveimmunecrosstalkinsarscov2mrnavaccination AT simonisalexander spleentyrosinekinasemediatesinnateandadaptiveimmunecrosstalkinsarscov2mrnavaccination AT mudlerjuliem spleentyrosinekinasemediatesinnateandadaptiveimmunecrosstalkinsarscov2mrnavaccination AT gobelulrike spleentyrosinekinasemediatesinnateandadaptiveimmunecrosstalkinsarscov2mrnavaccination AT actonrichard spleentyrosinekinasemediatesinnateandadaptiveimmunecrosstalkinsarscov2mrnavaccination AT kohlhasviktoria spleentyrosinekinasemediatesinnateandadaptiveimmunecrosstalkinsarscov2mrnavaccination AT albertmariechristine spleentyrosinekinasemediatesinnateandadaptiveimmunecrosstalkinsarscov2mrnavaccination AT hellmannannamaria spleentyrosinekinasemediatesinnateandadaptiveimmunecrosstalkinsarscov2mrnavaccination AT malinjakobj spleentyrosinekinasemediatesinnateandadaptiveimmunecrosstalkinsarscov2mrnavaccination AT wintersandra spleentyrosinekinasemediatesinnateandadaptiveimmunecrosstalkinsarscov2mrnavaccination AT hallekmichael spleentyrosinekinasemediatesinnateandadaptiveimmunecrosstalkinsarscov2mrnavaccination AT walczakhenning spleentyrosinekinasemediatesinnateandadaptiveimmunecrosstalkinsarscov2mrnavaccination AT nguyenphuonghien spleentyrosinekinasemediatesinnateandadaptiveimmunecrosstalkinsarscov2mrnavaccination AT kochmanuel spleentyrosinekinasemediatesinnateandadaptiveimmunecrosstalkinsarscov2mrnavaccination AT rybnikerjan spleentyrosinekinasemediatesinnateandadaptiveimmunecrosstalkinsarscov2mrnavaccination |